Tags

Type your tag names separated by a space and hit enter

Obesity-associated nonalcoholic fatty liver disease.
Clin Liver Dis 2014; 18(1):19-31CL

Abstract

Obesity is strongly associated with the prevalence of nonalcoholic fatty liver disease (NAFLD) in adult and pediatric populations. Nutrition, physical activity, and behavioral modifications are critical components of the treatment regimen for all obese patients with NAFLD. Bariatric surgeries that affect or restrict the flow of food through the gastrointestinal tract may improve liver histology in morbidly obese patients with nonalcoholic steatohepatitis (NASH), although randomized clinical trials and quasi-randomized clinical studies are lacking. Early detection of NASH and hepatic fibrosis using noninvasive biochemical and imaging markers that may replace liver biopsy is the current challenge.

Authors+Show Affiliations

Department of Gastroenterology, School of Medicine, Marmara University, Fevzi Cakmak Mah, Mimar Sinan Cad. No. 41 Ust Kaynarca, Pendik, Istanbul 34899, Turkey; Institute of Gastroenterology, Marmara University, Karaciger Arastirmalari Birimi, Basibuyuk, Maltepe, Istanbul 34840, Turkey.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

24274862

Citation

Yilmaz, Yusuf, and Zobair M. Younossi. "Obesity-associated Nonalcoholic Fatty Liver Disease." Clinics in Liver Disease, vol. 18, no. 1, 2014, pp. 19-31.
Yilmaz Y, Younossi ZM. Obesity-associated nonalcoholic fatty liver disease. Clin Liver Dis. 2014;18(1):19-31.
Yilmaz, Y., & Younossi, Z. M. (2014). Obesity-associated nonalcoholic fatty liver disease. Clinics in Liver Disease, 18(1), pp. 19-31. doi:10.1016/j.cld.2013.09.018.
Yilmaz Y, Younossi ZM. Obesity-associated Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2014;18(1):19-31. PubMed PMID: 24274862.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Obesity-associated nonalcoholic fatty liver disease. AU - Yilmaz,Yusuf, AU - Younossi,Zobair M, Y1 - 2013/10/24/ PY - 2013/11/27/entrez PY - 2013/11/28/pubmed PY - 2014/8/15/medline KW - Epidemiology KW - Nonalcoholic fatty liver disease KW - Obesity KW - Pathophysiology SP - 19 EP - 31 JF - Clinics in liver disease JO - Clin Liver Dis VL - 18 IS - 1 N2 - Obesity is strongly associated with the prevalence of nonalcoholic fatty liver disease (NAFLD) in adult and pediatric populations. Nutrition, physical activity, and behavioral modifications are critical components of the treatment regimen for all obese patients with NAFLD. Bariatric surgeries that affect or restrict the flow of food through the gastrointestinal tract may improve liver histology in morbidly obese patients with nonalcoholic steatohepatitis (NASH), although randomized clinical trials and quasi-randomized clinical studies are lacking. Early detection of NASH and hepatic fibrosis using noninvasive biochemical and imaging markers that may replace liver biopsy is the current challenge. SN - 1557-8224 UR - https://www.unboundmedicine.com/medline/citation/24274862/Obesity_associated_nonalcoholic_fatty_liver_disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1089-3261(13)00092-5 DB - PRIME DP - Unbound Medicine ER -